Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Impact of Sarcopenia on Dyspnea in Patients With Asthma

Authors not listed

University Hospital, Clermont-Ferrand · 2025

Abstract

Dyspnea in asthma, is mainly due to airway obstruction but can be caused by several alternative diagnoses. The impact of sarcopenia on dyspnea in patients with asthma is unknown. Sarcopenic asthma had a reduced physical activity and is associated with airway obstruction compared to non-sarcopenic asthma. In patients with obstructive pulmonary disease, sarcopenia is associated with shallow breathing and diverse sensory and affective components of exertional dyspnea . The morbidity of sarcopenia is also increased by systemic inflammation and the production of inflammatory cytokines as found in inflammatory airway obstruction. The investigators will investigate the prevalence and impact of sarcopenia in asthmatics patients. This will enable to better manage sarcopenia in asthmatic patients, understand its origins and personalize treatment.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-12 MST

Cite this

APA
Anonymous. (2025). Impact of Sarcopenia on Dyspnea in Patients With Asthma. <em>University Hospital, Clermont-Ferrand</em>. https://clinicaltrials.gov/study/NCT06870890
Vancouver
Anonymous. Impact of Sarcopenia on Dyspnea in Patients With Asthma. University Hospital, Clermont-Ferrand. 2025.
BibTeX
@misc{anon2025Impact, title = {Impact of Sarcopenia on Dyspnea in Patients With Asthma}, author = {Anonymous}, journal = {University Hospital, Clermont-Ferrand}, year = {2025}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings